illustrative image

Our Company is Committed to Corporate Social Responsibility (CSR)

We understand that our actions go beyond financial success, and we strive to integrate ethical practices into every aspect of our corporate governance and operations. Through our CSR initiatives, we actively engage in various social, societal and environmental causes, such as supporting local communities, promoting sustainability, and championing diversity and inclusion.

Our Purpose

Our purpose supports our long-term commitment to the role we want to play in society, not only as an economic player seeking to create long-term value for our ecosystem and partners, but also as an innovative biotechnology company working to improve patients’ quality of life and as a civic company striving to promote professional and personal development for its employees.

We intend to create general public benefit by generating a positive and significant social, societal and environmental impact through our activities. As part of this approach, our Board of Directors commits to taking into consideration the social, societal and environmental consequences of its decisions on all of the Company’s stakeholders, and the consequences of its decisions on the environment.

As part of this commitment, we have created a dedicated Environmental, Social, Governance (ESG), Committee of the Board of Directors which meets at least bi-annually, to measure and track our extra-financial performance and communicate to the public through an annual extra-financial performance report.

Our Core Values

Innovation to Serve Patients

We are deeply committed to improving the health and quality of life of patients affected by rare and life-threatening liver diseases characterized by high unmet medical needs. We seek new ways to advance science and medicine, with the goal of optimizing care for patients. With a strong desire to leverage our agility and responsiveness, we and our employees are striving to move our scientific and medical approaches forward, and improve patient management in terms of diagnostics, prevention and care.

Respect and Diversity

We bring together talented employees with unique perspectives and experiences. We recognize and value diversity as a great strength and ensure that all employees and third parties are treated fairly, with dignity and respect.

Ethics

We deliver true and accurate information to our partners and stakeholders and build our business relationships with honesty and transparency. We demand of ourselves and others the highest ethical standards, and we conduct our business in a socially and environmentally sustainable manner.

A word from the Chair Woman of the ESG Committee

Picture of Catherine Larue, the Chair Woman of the ESG Committee

A company can create value for its shareholders while integrating a social and environmental dimension into its objectives and its mode of governance. All of GENFIT’s employees and directors are committed to this approach, and the company’s growth dynamic is strengthened as a result. CSR initiatives – which help to materialize the company’s social and environmental responsibility – contribute to the improvement of its overall performance and the motivation of its employees.

Catherine LARUE

Our Voluntary commitments

We commit to and follow different sets of national and international standards that allow us to pilot our CSR trajectory.

  • We are committed to the 10 principles of the United Nations Global Compact
  • We translate our vision into our roadmap which is based on the UN’s 17 Sustainable Development Goals
  • We follow the new recommendations of the MiddleNext Governance Code
  • We formalize our reporting following ISO26000, SASB, GRI and SDGs standards
  • We have been part of the “Responsibility and Reputation” commission of the LEEM1 
  • We consider with interest the elements of the PACTE Law
  • We are a signatory of the regional PAQTE2

Societal

As a healthcare company striving to make a positive contribution to society, societal issues are at the forefront of our minds. The health of individuals is at the core of our activity, and we prioritize therapeutic areas for patients with particularly high medical needs. We also endeavor to develop specific initiatives aimed at providing benefit to our business ecosystem, to our local ecosystem, or to population in needs in general. 

Social

At GENFIT, fostering innovation relies on creating an environment where employees can freely exchange ideas, engage in dialogue, and collaborate while upholding the scientific process. As such, attracting, protecting and developing our human capital is a critical element that we prioritize alongside our commitment to Society. We commit to ensuring that diversity (in all its forms), inclusion and quality of work life are driving forces.

Governance

We coordinate our activities with a system of corporate governance that meets demanding criteria in terms of ethics, responsibility and fairness. We consider that our non-financial performance serves our financial performance (and our business model), in the interest of our stakeholders including patients, investors, partners and employees. Our governance ensures that our practices are compliant with standards from international health authorities as well as financial market authorities, with the ultimate objective of ensuring the Company’s sustainability while doing the right thing.

Environment

Climate change and pollution are ultimately related to healthcare, our sector. This is one of the reasons why we want to make our business  environmentally sustainable, through a better measurement of our impact, enhanced prevention of risks, and better waste management. Although our consumption of raw materials and environmental emissions are relatively limited by nature – due to our activity and our size – we wish to take a proactive approach in reducing environmental damage.

Our commitment to CSR has garnered recognition from esteemed labels and institutions, affirming our dedication to making a positive impact in society and the environment. 

ISS (Institutional Shareholder Services) ESG granted 'Prime' status to GENFIT in 2023
Gold Medal from Ethifinance for the 2023 ESG rating based on the 2022 activity.
ODDO BHF Sustainability Research - « Best-in class » European Biotech Sector

Our Employees

Patrick – Deputy CFO
Émeline – Cross-Functional Project Manager
Nicolas – Bioinformatician
Genevi̬ve РPatent Engineer

Our Website is Sustainably Designed

  • reduce our carbon footprint and therefore our environmental impact (by limiting the weight of images, the number of requests, by not hosting any videos, etc.)
  • make our site accessible and inclusive (color contrast for better legibility, provide accurate metadata descriptions for visually impaired viewers, etc.).

1Les Entreprises du Médicament, the French Pharmaceutical Companies Association
2 Pacte Avec les Quartiers pour Toutes les Entreprises